Efficacy and Safety of Switching From Intravenous to Subcutaneous Infliximab for Psoriasis: A Case Series

Conor Larney; Peter Foley; Kurt Gebauer; Benjamin S. Daniel

doi:10.1111/ajd.14409

Efficacy and Safety of Switching From Intravenous to Subcutaneous Infliximab for Psoriasis: A Case Series

Conor Larney, Peter Foley, Kurt Gebauer, Benjamin S. Daniel

Internal Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e49-e51
Journal	Australasian Journal of Dermatology
Volume	66
Issue number	2
Early online date	31 Dec 2024
DOIs	https://doi.org/10.1111/ajd.14409
Publication status	Published - 2025

Access to Document

10.1111/ajd.14409

Cite this

@article{e6118040801645afac5bafd9e0dc3f11,

title = "Efficacy and Safety of Switching From Intravenous to Subcutaneous Infliximab for Psoriasis: A Case Series",

keywords = "infliximab, intravenous, psoriasis, subcutaneous",

author = "Conor Larney and Peter Foley and Kurt Gebauer and Daniel, {Benjamin S.}",

year = "2025",

doi = "10.1111/ajd.14409",

language = "English",

volume = "66",

pages = "e49--e51",

journal = "Australasian Journal of Dermatology",

issn = "0004-8380",

publisher = "John Wiley & Sons",

number = "2",

}

TY - JOUR

T1 - Efficacy and Safety of Switching From Intravenous to Subcutaneous Infliximab for Psoriasis

T2 - A Case Series

AU - Larney, Conor

AU - Foley, Peter

AU - Gebauer, Kurt

AU - Daniel, Benjamin S.

PY - 2025

Y1 - 2025

KW - infliximab

KW - intravenous

KW - psoriasis

KW - subcutaneous

UR - http://www.scopus.com/inward/record.url?scp=85213885431&partnerID=8YFLogxK

U2 - 10.1111/ajd.14409

DO - 10.1111/ajd.14409

M3 - Letter

C2 - 39739520

AN - SCOPUS:85213885431

SN - 0004-8380

VL - 66

SP - e49-e51

JO - Australasian Journal of Dermatology

JF - Australasian Journal of Dermatology

IS - 2

ER -

Efficacy and Safety of Switching From Intravenous to Subcutaneous Infliximab for Psoriasis: A Case Series

Access to Document

Other files and links

Cite this